Jonsson Cancer Center Foundation- Ucla is located in Los Angeles, CA. The organization was established in 1958. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Jonsson Cancer Center Foundation- Ucla is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2021, Jonsson Cancer Center Foundation- Ucla generated $13.2m in total revenue. This represents relatively stable growth, over the past 5 years the organization has increased revenue by an average of 3.4% each year. All expenses for the organization totaled $13.8m during the year ending 06/2021. While expenses have increased by 6.2% per year over the past 5 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE JONSSON CANCER CENTER FOUNDATION IS THE SINGLE MOST IMPORTANT VEHICLE FOR RAISING PRIVATE FUNDS FOR CANCER RESEARCH AT UCLA. PLEASE SEE SCHEDULE O.
Describe the Organization's Program Activity:
Part 3 - Line 4a
DONOR DIRECTED GRANTS: UCLA'S JONSSON COMPREHENSIVE CANCER CENTER (JCCC) IS DEDICATED TO FUNDAMENTAL RESEARCH ON A BROAD VARIETY OF HUMAN CANCERS AND TO THE DEVELOPMENT OF NEW PROTOCOLS FOR THEIR TREATMENT. CONTRIBUTIONS RECEIVED FOR THE PURPOSE OF SUPPORTING DONOR-DESIGNATED AREAS AND/OR INVESTIGATORS AS WELL AS RESEARCH PRIORITIES IDENTIFIED BY THE JCCC ACADEMIC LEADERSHIP ARE DIRECTED TO PROJECTS CONSISTENT WITH THE SPECIFIED DONOR INTENT.
SEED AND IMPACT GRANTS: SEED GRANTS STARTUP FUNDING SUPPORTS YOUNG INVESTIGATORS AT THE BEGINNING OF THEIR CAREERS WHEN IT WILL MAKE THE GREATEST DIFFERENCE OR SUPPORTS ESTABLISHED INVESTIGATORS EXPLORING A NEW LANE OF RESEARCH. IMPACT GRANTS ARE COLLABORATION AMONG THREE OR MORE JCCC FACULTY MEMBERS SPECIALIZING IN A WIDE RANGE OF RESEARCH AREAS CRITICAL TO ADVANCING THE FIGHT AGAINST CANCER.
DIRECTOR'S DISCOVERY: DIRECTOR'S DISCOVERY FUNDING PROVIDES THE JONSSON COMPREHENSIVE CANCER CENTER DIRECTOR THE OPPORTUNITY TO DEFTLY PARTICIPATE IN PREVIOUSLY UNANTICIPATED, NEW OPPORTUNITIES TO SUPPORT FACULTY, INFRASTRUCTURE, AND PROGRAMS THAT WILL ACCELERATE CANCER RESEARCH.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Melissa Brody Director, Stewardship | 40 | $137,530 | |
Francesca Cota Director Of Development | 40 | $121,710 | |
Jacqueline Farina Director Strategic Partnership | 40 | $115,162 | |
Dana Walden Vice-Chair | OfficerTrustee | 1 | $0 |
Dr Michael A Teitell President | OfficerTrustee | 1 | $0 |
Jordan Walder Treasurer | OfficerTrustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $12,945,107 |
Noncash contributions included in lines 1a–1f | $2,170,241 |
Total Revenue from Contributions, Gifts, Grants & Similar | $12,945,107 |
Total Program Service Revenue | $0 |
Investment income | $99,973 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $141,967 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $13,187,047 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $12,900,762 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $0 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $0 |
Fees for services: Legal | $0 |
Fees for services: Accounting | $18,100 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $44,960 |
Advertising and promotion | $0 |
Office expenses | $12,739 |
Information technology | $61,636 |
Royalties | $0 |
Occupancy | $0 |
Travel | $0 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $0 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $0 |
All other expenses | $0 |
Total functional expenses | $13,766,501 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $334,349 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $7,298,644 |
Accounts receivable, net | $1,203,420 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $321,660 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $20,007,065 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $169,359 |
Total assets | $29,334,497 |
Accounts payable and accrued expenses | $811,303 |
Grants payable | $0 |
Deferred revenue | $297,804 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $1,109,107 |
Net assets without donor restrictions | $11,632,496 |
Net assets with donor restrictions | $16,592,894 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $29,334,497 |
Over the last fiscal year, Jonsson Cancer Center Foundation- Ucla has awarded $12,685,305 in support to 2 organizations.
Grant Recipient | Amount |
---|---|
Los Angeles, CA PURPOSE: RESEARCH SUPPORT | $11,487,671 |
Los Angeles, CA PURPOSE: RESEARCH SUPPORT | $1,197,634 |
Over the last fiscal year, we have identified 52 grants that Jonsson Cancer Center Foundation- Ucla has recieved totaling $1,207,504.
Awarding Organization | Amount |
---|---|
Kure It Inc Irvine, CA PURPOSE: TO FUND CANCER RESEARCH | $150,000 |
Schwab Charitable Fund San Francisco, CA PURPOSE: HEALTH | $134,650 |
Rar Family Foundation Los Angeles, CA PURPOSE: GENERAL SUPPORT | $122,042 |
Carl And Roberta Deutsch Foundation Santa Monica, CA PURPOSE: HEALTH | $120,000 |
Sun Moon And Stars Foundation Inc Fort Lauderdale, FL PURPOSE: CANCER RESEARCH | $75,000 |
Wolfen Family Foundation Encino, CA PURPOSE: CHARITABLE | $50,000 |
Organization Name | Assets | Revenue |
---|---|---|
Jonsson Cancer Center Foundation- Ucla Los Angeles, CA | $29,334,497 | $13,187,047 |
Translational Research In Oncology Us Inc Los Angeles, CA | $23,537,777 | $8,265,596 |
Pediatric Cancer Research Foundation Irvine, CA | $3,627,407 | $2,821,956 |
Nevada Cancer Research Foundation Inc Las Vegas, NV | $637,661 | $2,412,271 |
The International Genomics Consortium Phoenix, AZ | $13,871,737 | $3,350,681 |
Cancer Prevention Institute of California (CPIC) Foster City, CA | $0 | $44,595 |
Vanguard Cancer Foundation Long Beach, CA | $1,374,337 | $177,388 |
Prostate Cancer Research Institute Culver City, CA | $2,240,081 | $999,786 |
Keatons Child Cancer Alliance Roseville, CA | $375,909 | $787,785 |
Ethos Discovery San Diego, CA | $1,024,175 | $920,855 |
Sino-American Cancer Foundation Arcadia, CA | $0 | $1,131,529 |
Grassrootshealth Encinitas, CA | $16,808 | $760,113 |